We previously showed that GZD824 suppresses Ph+ CML cells and induces tumor regression in mouse xenograft tumor models by inhibiting BCR-ABL kinase [16, 17]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.